retatrutide glp-1 gip glucagon receptor agonist Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Retatrutide Api Triple Gip Glp-1
Description
Trends Cardiovasc Med 33(3):159166 Lepsen EW, Lundgren JR, Hartmann B et al (2015) GLP-1 receptor agonist treatment increases bone formation and prevents bone loss in weight-reduced obese women
Endocrinology, 151:1473-1486
[DOI] [PMC free article] [PubMed] [Google Scholar] 12.Kim G., Lee S.G., Lee B.W., Kang E.S., Cha B.S., Ferrannini E., Lee Y.H., Cho N.H
In addition, large single doses especially on an empty stomach may increase the chance of digestive discomfort, which is one reason allulose tends to be self-limiting
